Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma

Publication Date

2024

Content Type

Article

PubMed ID:

38900987

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS